Feds target joint docs in kickbacks probe

Share this article:
Federal investigators are zeroing in on individual hip and knee surgeons in an investigation into kickbacks to doctors by orthopedic device manufacturers, The New York Times reports.

US attorney for the district of New Jersey Christopher Christie recently addressed the sales meetings of five companies, the Times said, quoting a Stryker executive as saying Christie told them “I've dealt with the supply issue, now I need to deal with the demand issue.”

Four companies – Biomet, Johnson & Johnson's DePuy Orthopaedics, Smith & Nephew and Zimmer Holdings – agreed to pay a combined total of $310 million to settle civil charges related to the inquest in September. Stryker was included in that settlement but did not pay a fine, as it was the first to cooperate in the investigation. All entered corporate integrity agreements.

The firms were accused of paying kickbacks to doctors in the form of consulting fees in exchange for recommending their products to patients.
Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...